A hybrid endocardial‐epicardial biventricular implantable cardioverter‐defibrillator to circumvent the tricuspid valve
The development of pacing and defibrillator systems that do not involve hardware traversing the tricuspid annulus can be desirable in order to minimize lead‐related complications such as tricuspid regurgitation. Occasionally, primary tricuspid valve pathology (ie, infectious endocarditis, nonbacteri...
Gespeichert in:
| Veröffentlicht in: | Pacing and clinical electrophysiology 2021-02, Vol.44 (2), p.399-401 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 401 |
|---|---|
| container_issue | 2 |
| container_start_page | 399 |
| container_title | Pacing and clinical electrophysiology |
| container_volume | 44 |
| creator | Ip, James E. Krishnan, Udhay Girardi, Leonard N. Lerman, Bruce B. |
| description | The development of pacing and defibrillator systems that do not involve hardware traversing the tricuspid annulus can be desirable in order to minimize lead‐related complications such as tricuspid regurgitation. Occasionally, primary tricuspid valve pathology (ie, infectious endocarditis, nonbacterial thrombotic endocarditis, and carcinoid disease) or congenital heart disease prohibits use of transvenous leads and alternative strategies are required to provide pacing or defibrillation. We describe such a case in which a biventricular implantable cardioverter defibrillator was implanted using a hybrid system involving endocardial and epicardial components. |
| doi_str_mv | 10.1111/pace.14099 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2452976816</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2452976816</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3579-b50e7ba23bf2d0815bef99b87df1aff3512c9bc72f1115adfb0547eb44df4e653</originalsourceid><addsrcrecordid>eNp9kctqGzEUhkVJqJ20mz5AEWQTApNKM5JntDQmNwiki3Y96HJEZDSXSjMOziqPkGfMk0T2uFl0UYEQgu985xx-hL5RcknT-dFLDZeUESE-oTnljGQV5eIIzQllZVYVlZihkxjXhJAFYfwzmhUFqXgqnaPnJX7cquAMhtZ0WgbjpH97eYXeHT5YuQ20Q3B69DJg1_RetoNUHvCe6DYQBgipxoB1SeW9HLqAhw5rF_TY7Krx8Ah474h96rWRfgNf0LGVPsLXw3uKfl9f_VrdZvcPN3er5X2mC16KTHECpZJ5oWxuSNpMgRVCVaWxVFpbcJproXSZ27QQl8YqwlkJijFjGSx4cYrOJ28fuj8jxKFuXNSQxmyhG2OdM56LclHRRULP_kHX3RjaNF2iqoqmS1iiLiZKhy7GALbug2tk2NaU1LtE6l0i9T6RBH8_KEfVgPlA_0aQADoBT87D9j-q-udydTVJ3wHQ4Zs5</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2488148804</pqid></control><display><type>article</type><title>A hybrid endocardial‐epicardial biventricular implantable cardioverter‐defibrillator to circumvent the tricuspid valve</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Ip, James E. ; Krishnan, Udhay ; Girardi, Leonard N. ; Lerman, Bruce B.</creator><creatorcontrib>Ip, James E. ; Krishnan, Udhay ; Girardi, Leonard N. ; Lerman, Bruce B.</creatorcontrib><description>The development of pacing and defibrillator systems that do not involve hardware traversing the tricuspid annulus can be desirable in order to minimize lead‐related complications such as tricuspid regurgitation. Occasionally, primary tricuspid valve pathology (ie, infectious endocarditis, nonbacterial thrombotic endocarditis, and carcinoid disease) or congenital heart disease prohibits use of transvenous leads and alternative strategies are required to provide pacing or defibrillation. We describe such a case in which a biventricular implantable cardioverter defibrillator was implanted using a hybrid system involving endocardial and epicardial components.</description><identifier>ISSN: 0147-8389</identifier><identifier>EISSN: 1540-8159</identifier><identifier>DOI: 10.1111/pace.14099</identifier><identifier>PMID: 33085111</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>cardiac resynchronization therapy ; Coronary artery disease ; Defibrillators ; Defibrillators, Implantable ; Endocarditis ; Endocardium ; epicardial ; Equipment Design ; Heart diseases ; Humans ; implantable cardioverter defibrillator ; Male ; Middle Aged ; pacemaker ; Pericardium ; Regurgitation ; Rheumatic heart disease ; tricuspid regurgitation ; Tricuspid Valve ; Tricuspid Valve Insufficiency - prevention & control</subject><ispartof>Pacing and clinical electrophysiology, 2021-02, Vol.44 (2), p.399-401</ispartof><rights>2020 Wiley Periodicals LLC</rights><rights>2020 Wiley Periodicals LLC.</rights><rights>2021 Wiley Periodicals LLC</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3579-b50e7ba23bf2d0815bef99b87df1aff3512c9bc72f1115adfb0547eb44df4e653</citedby><cites>FETCH-LOGICAL-c3579-b50e7ba23bf2d0815bef99b87df1aff3512c9bc72f1115adfb0547eb44df4e653</cites><orcidid>0000-0001-6780-2903 ; 0000-0002-3461-505X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fpace.14099$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fpace.14099$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33085111$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ip, James E.</creatorcontrib><creatorcontrib>Krishnan, Udhay</creatorcontrib><creatorcontrib>Girardi, Leonard N.</creatorcontrib><creatorcontrib>Lerman, Bruce B.</creatorcontrib><title>A hybrid endocardial‐epicardial biventricular implantable cardioverter‐defibrillator to circumvent the tricuspid valve</title><title>Pacing and clinical electrophysiology</title><addtitle>Pacing Clin Electrophysiol</addtitle><description>The development of pacing and defibrillator systems that do not involve hardware traversing the tricuspid annulus can be desirable in order to minimize lead‐related complications such as tricuspid regurgitation. Occasionally, primary tricuspid valve pathology (ie, infectious endocarditis, nonbacterial thrombotic endocarditis, and carcinoid disease) or congenital heart disease prohibits use of transvenous leads and alternative strategies are required to provide pacing or defibrillation. We describe such a case in which a biventricular implantable cardioverter defibrillator was implanted using a hybrid system involving endocardial and epicardial components.</description><subject>cardiac resynchronization therapy</subject><subject>Coronary artery disease</subject><subject>Defibrillators</subject><subject>Defibrillators, Implantable</subject><subject>Endocarditis</subject><subject>Endocardium</subject><subject>epicardial</subject><subject>Equipment Design</subject><subject>Heart diseases</subject><subject>Humans</subject><subject>implantable cardioverter defibrillator</subject><subject>Male</subject><subject>Middle Aged</subject><subject>pacemaker</subject><subject>Pericardium</subject><subject>Regurgitation</subject><subject>Rheumatic heart disease</subject><subject>tricuspid regurgitation</subject><subject>Tricuspid Valve</subject><subject>Tricuspid Valve Insufficiency - prevention & control</subject><issn>0147-8389</issn><issn>1540-8159</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kctqGzEUhkVJqJ20mz5AEWQTApNKM5JntDQmNwiki3Y96HJEZDSXSjMOziqPkGfMk0T2uFl0UYEQgu985xx-hL5RcknT-dFLDZeUESE-oTnljGQV5eIIzQllZVYVlZihkxjXhJAFYfwzmhUFqXgqnaPnJX7cquAMhtZ0WgbjpH97eYXeHT5YuQ20Q3B69DJg1_RetoNUHvCe6DYQBgipxoB1SeW9HLqAhw5rF_TY7Krx8Ah474h96rWRfgNf0LGVPsLXw3uKfl9f_VrdZvcPN3er5X2mC16KTHECpZJ5oWxuSNpMgRVCVaWxVFpbcJproXSZ27QQl8YqwlkJijFjGSx4cYrOJ28fuj8jxKFuXNSQxmyhG2OdM56LclHRRULP_kHX3RjaNF2iqoqmS1iiLiZKhy7GALbug2tk2NaU1LtE6l0i9T6RBH8_KEfVgPlA_0aQADoBT87D9j-q-udydTVJ3wHQ4Zs5</recordid><startdate>202102</startdate><enddate>202102</enddate><creator>Ip, James E.</creator><creator>Krishnan, Udhay</creator><creator>Girardi, Leonard N.</creator><creator>Lerman, Bruce B.</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>NAPCQ</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-6780-2903</orcidid><orcidid>https://orcid.org/0000-0002-3461-505X</orcidid></search><sort><creationdate>202102</creationdate><title>A hybrid endocardial‐epicardial biventricular implantable cardioverter‐defibrillator to circumvent the tricuspid valve</title><author>Ip, James E. ; Krishnan, Udhay ; Girardi, Leonard N. ; Lerman, Bruce B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3579-b50e7ba23bf2d0815bef99b87df1aff3512c9bc72f1115adfb0547eb44df4e653</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>cardiac resynchronization therapy</topic><topic>Coronary artery disease</topic><topic>Defibrillators</topic><topic>Defibrillators, Implantable</topic><topic>Endocarditis</topic><topic>Endocardium</topic><topic>epicardial</topic><topic>Equipment Design</topic><topic>Heart diseases</topic><topic>Humans</topic><topic>implantable cardioverter defibrillator</topic><topic>Male</topic><topic>Middle Aged</topic><topic>pacemaker</topic><topic>Pericardium</topic><topic>Regurgitation</topic><topic>Rheumatic heart disease</topic><topic>tricuspid regurgitation</topic><topic>Tricuspid Valve</topic><topic>Tricuspid Valve Insufficiency - prevention & control</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ip, James E.</creatorcontrib><creatorcontrib>Krishnan, Udhay</creatorcontrib><creatorcontrib>Girardi, Leonard N.</creatorcontrib><creatorcontrib>Lerman, Bruce B.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Pacing and clinical electrophysiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ip, James E.</au><au>Krishnan, Udhay</au><au>Girardi, Leonard N.</au><au>Lerman, Bruce B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A hybrid endocardial‐epicardial biventricular implantable cardioverter‐defibrillator to circumvent the tricuspid valve</atitle><jtitle>Pacing and clinical electrophysiology</jtitle><addtitle>Pacing Clin Electrophysiol</addtitle><date>2021-02</date><risdate>2021</risdate><volume>44</volume><issue>2</issue><spage>399</spage><epage>401</epage><pages>399-401</pages><issn>0147-8389</issn><eissn>1540-8159</eissn><abstract>The development of pacing and defibrillator systems that do not involve hardware traversing the tricuspid annulus can be desirable in order to minimize lead‐related complications such as tricuspid regurgitation. Occasionally, primary tricuspid valve pathology (ie, infectious endocarditis, nonbacterial thrombotic endocarditis, and carcinoid disease) or congenital heart disease prohibits use of transvenous leads and alternative strategies are required to provide pacing or defibrillation. We describe such a case in which a biventricular implantable cardioverter defibrillator was implanted using a hybrid system involving endocardial and epicardial components.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>33085111</pmid><doi>10.1111/pace.14099</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0001-6780-2903</orcidid><orcidid>https://orcid.org/0000-0002-3461-505X</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0147-8389 |
| ispartof | Pacing and clinical electrophysiology, 2021-02, Vol.44 (2), p.399-401 |
| issn | 0147-8389 1540-8159 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2452976816 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
| subjects | cardiac resynchronization therapy Coronary artery disease Defibrillators Defibrillators, Implantable Endocarditis Endocardium epicardial Equipment Design Heart diseases Humans implantable cardioverter defibrillator Male Middle Aged pacemaker Pericardium Regurgitation Rheumatic heart disease tricuspid regurgitation Tricuspid Valve Tricuspid Valve Insufficiency - prevention & control |
| title | A hybrid endocardial‐epicardial biventricular implantable cardioverter‐defibrillator to circumvent the tricuspid valve |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T19%3A47%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20hybrid%20endocardial%E2%80%90epicardial%20biventricular%20implantable%20cardioverter%E2%80%90defibrillator%20to%20circumvent%20the%20tricuspid%20valve&rft.jtitle=Pacing%20and%20clinical%20electrophysiology&rft.au=Ip,%20James%20E.&rft.date=2021-02&rft.volume=44&rft.issue=2&rft.spage=399&rft.epage=401&rft.pages=399-401&rft.issn=0147-8389&rft.eissn=1540-8159&rft_id=info:doi/10.1111/pace.14099&rft_dat=%3Cproquest_cross%3E2452976816%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2488148804&rft_id=info:pmid/33085111&rfr_iscdi=true |